Intercontinental Wealth Advisors, LLC Novo Nordisk A S Transaction History

Intercontinental Wealth Advisors, LLC

$416 Million
Q2 2023

A detailed history of Intercontinental Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Intercontinental Wealth Advisors, LLC holds 9,362 shares of NVO stock, worth $1.33 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

9,362

Previous 9,778 4.25%

Holding current value

$1.33 Million

Previous $1.56 Million 2.63%

% of portfolio

0.36%

Previous 0.4%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	SELL	$155.98 - $172.65 $64,887 - $71,822	-416 Reduced 4.25%	9,362 $1.52 Million
Q1 2023 May 03, 2023	SELL	$132.34 - $159.14 $267,062 - $321,144	-2,018 Reduced 17.11%	9,778 $1.56 Million
Q4 2022 Feb 13, 2023	SELL	$102.55 - $135.33 $466,089 - $615,074	-4,545 Reduced 27.81%	11,796 $1.6 Million
Q3 2022 Nov 10, 2022	SELL	$95.28 - $116.93 $33,157 - $40,691	-348 Reduced 2.09%	16,341 $1.63 Million
Q2 2022 Aug 05, 2022	SELL	$103.24 - $121.81 $108,711 - $128,265	-1,053 Reduced 5.94%	16,689 $1.86 Million

Q1 2022 May 09, 2022	SELL	$93.1 - $112.54 $57,815 - $69,887	-621 Reduced 3.38%	17,742 $1.97 Million
Q4 2021 Feb 08, 2022	SELL	$95.88 - $117.08 $82,744 - $101,040	-863 Reduced 4.49%	18,363 $2.06 Million
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $424,885 - $536,618	-5,033 Reduced 20.75%	19,226 $1.85 Million
Q2 2021 Aug 06, 2021	BUY	$67.66 - $84.76 $115,157 - $144,261	1,702 Added 7.55%	24,259 $2.03 Million
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $166,912 - $188,715	2,489 Added 12.4%	22,557 $1.52 Million
Q4 2020 Feb 19, 2021	BUY	$63.89 - $73.8 $510,353 - $589,514	7,988 Added 66.13%	20,068 $1.4 Million
Q3 2020 Mar 10, 2021	BUY	$63.69 - $70.22 $482,770 - $532,267	7,580 Added 168.44%	12,080 $839,000
Q3 2020 Jan 19, 2021	SELL	$63.69 - $70.22 $4,394 - $4,845	-69 Reduced 1.51%	4,500 $233,000
Q2 2020 Mar 10, 2021	BUY	$58.54 - $67.94 $267,469 - $310,417	4,569 New	4,569 $299,000
Q2 2020 Jan 19, 2021	SELL	$58.54 - $67.94 $263,430 - $305,730	-4,500 Closed	0 $0
Q1 2020 Mar 10, 2021	BUY	$49.46 - $64.78 $222,570 - $291,510	4,500 New	4,500 $271,000
Q1 2020 Jan 19, 2021	SELL	$49.46 - $64.78 $232,560 - $304,595	-4,702 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$49.86 - $58.26 $10,071 - $11,768	202 Added 4.49%	4,702 $303,000
Q3 2019 Oct 09, 2019	BUY	$47.54 - $53.43 $213,930 - $240,435	4,500 New	4,500 $233,000

Others Institutions Holding NVO

# of Institutions

1,861

Shares Held

310M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $321B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intercontinental Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intercontinental Wealth Advisors, LLC with notifications on news.

Account

Intercontinental Wealth Advisors, LLC Novo Nordisk A S Transaction History